BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Farmers Insurance

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,760,072

« Back to Dashboard

Summary for Patent: 4,760,072

Title: Solid nedocromil sodium, useful for the removal of obstructed air pathways
Abstract:There are described new forms of nedocromil sodium, methods of producing these new forms and pharmaceutical formulations, especially pressurized inhalation aerosol formulations, containing finely divided nedocromil sodium. The formulations are indicated for the treatment of reversible obstructive conditions of the airways.
Inventor(s): Brown; Kenneth (Loughborough, GB2), Clark; Andrew R. (Loughborough, GB2), Salliss; Richard (Holmes Chapel, GB2)
Assignee: Fisons, plc (Ipswich, GB2)
Application Number:06/720,588
Patent Claim Types:
see list of patent claims
Use; Formulation;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,760,072

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8409705Apr 13, 1984
United Kingdom8423634Sep 19, 1984

International Patent Family for Patent: 4,760,072

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece850916► Subscribe
United Kingdom8423634► Subscribe
France2563105► Subscribe
United Kingdom8508782► Subscribe
United Kingdom2157291► Subscribe
United Kingdom8721982► Subscribe
United Kingdom2196254► Subscribe
United Kingdom8409705► Subscribe
Finland90942► Subscribe
European Patent Office0162556► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Department of Justice
Chinese Patent Office
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: